RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA

Clinical trials for RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted drug trial aims to keep pancreatic cancer from coming back

Disease control Recruiting now

This study is testing if adding the drug olaparib after surgery and chemotherapy can help prevent pancreatic cancer from returning. It is for patients whose cancer has been surgically removed and who have specific genetic mutations (BRCA1, BRCA2, or PALB2). Participants will take…

Matched conditions: RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA

Get alerted when new RESECTABLE PANCREATIC ADENOSQUAMOUS CARCINOMA trials appear

Targeted drug trial aims to keep pancreatic cancer from coming back